< | up | >
Age related EBV associated LPD (5832)
Age related EBV associated LPDclosed
paantraštė: B08-16708
rūšis:
lymph node and BMB
siuntėjas:
ugnius
2008-06-20 16:46
INCTR - EBMWG Hematopathology Online
67 yrs female with clinically indolent disease, fatigue, lymphadenopathy.  
Axillary lymph node biopsy and threpine biopsy was performed. Unfortunatelly the patient was deceased soon after biopsy.  
FULL HISTORY: 2007 acute pneumonia and uncertain hepatosplenomegaly. 2008 deep anemia and transfusions. Massive visceral lymphadenopathy and hepatosplenomegaly, subfebrile fever. Due to positive blood culture (Gram(-)) the patient was hospitalized (sepsis). Infiltration in the left lung, pleuritis hypoechoic nodules up to 3cm in the spleen were found. Therapy: antibiotics, duretics and transfusions. Due to dyspnea and progressing bacteriemic shock the patient was deceased. The autopsy was declined. EBV evaluation was not done.  
HISTO: 1. NODE: Focal cHL picture with a reach of tumor cells areas DLBCL like.  
IH: CD20+; CD30+; CD15-; EBV LMP1+; LCA+; CylinD1-; EMA-; p53+; Mum1+; Bcl6- (single +, low quality); CD10-. BM: 2 deformed nidus of fibrosis with atypical cells (HL like picture):CD20+; CD30+/-; CD15- (LOW QUALITY).  
 
DIFFERENTIAL: CLASSIC EBV+ HOGDKIN'S LYMPHOMA (VARIANT?) vs EBV DRIVEN B LYMPHOPROLIFERATION/DLBCL.
anotacija » pridėti komentarą (prisijungti)
yethuwin
2008-06-22 07:32
you should consider of lymphocyte-rich type hodgkin lymphoma.
tzankov
2008-06-23 09:52
Small cells are infected by EBV, the large cells are CD15-, CD45+, thus Hodgkin lymphoma apperas not to be the differential diagnosis of first choise. In a post-trabsplant setting I would call this disease Hodgkin-like PTLD, but here, without obvious imunocompromize, the most proper designation would be probably senile EBV+ LPD. Importnatly, these diseases are not "indolent".  
 
see also:  
 
Cancer Sci. 2008 Jun;99(6):1085-91. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S.
ugnius
2008-06-23 11:37
Thank you. Please find full history of the patient. After clinicians: alcohol use anamnesis. EBV status is unclear.
tzankov
2008-06-23 13:43
Well, in my opinion (Tzankov A, Brunhuber T, Gschwendtner A, Brunner A. Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion. Histopathology. 2005; 46(3):348-50) alcoholism is an imunocompromizin factor; in addition the patient is >65. Thus, "senile EBV+ LPD" is still the best designation of the process.
hurwitz
2008-06-23 17:15
I have observed a number of practically identical cases, most of them incidental findings in elderly patients (>65), occuring often terminally (weeks before the pateint's death). Morphology identical to your case, HD-like cells, CD20+, CD45+, CD30+, and LMP1+.  
I agree with Dr.Tzankov, this is an EBV driven lymphoprolifera- tion in an elderly patient. Factors in favour of immodefficiency are: age and alcoholism. Gram- septicemia is probably another expression of a deficient immune system.  
I doubt that this is an indolent disease Is there any possibility to find out for how long the lymphadenopathy did exist ?
ugnius
2008-06-23 17:31
Thanx. The duration of lymphadenopathy at least 1 year.
k.naresh
2008-06-23 21:46
I am not sure if most of the large lymphoid cells are positive for CD45 (LCA). Much of the positivity is from the surrounding cells. CD45 is possibly negative in a good proportion of the large cells.  
 
CD20 expression is also heterogeneous and some cells are negative.  
 
I would interpret this case as classical Hodgkin lymphoma, which also involves the marrow (stage 4).  
tzankov
2008-06-25 16:32
one very strong argument against hodgkin (along with the lacking pathognominic cells) is the distribution of the LMP1-positivity. if one assumes that this is a hodgkin, so a coincidental acute mononucleosis should be present as well, but this model would be, in face of the lacking expression of CD15 and the unequivocal expression of CD45 even in a proportion of tumor cells, rather hypothetic. as I mentioned previously, in a post-transplant setting this would be a hodgkin-like PTLD (an aggressive disease), but here the designation senile EBV+ LPD would be the most proper one. CD79a (in addition oct2 and bob.1) might be helpful (probably negative in HL and probably positive in LPD).
SergeyN
2008-06-25 21:53
"the key to distinguishing between these EBV+ B cell LPDs and EBV+ HL now depends on recognition of the degree of expression of B cell markers, such as CD20 and CD79a, on the tumor cells. EBV+ B cell LPD is always characterized by the expression of CD20 and CD79a and is associated with light chain restriction in many of large cells" (see http://www.jsltr.org/journal/46-1/4601_01.pdf)  
 
I would support Dr.Tzankov's request for CD79a in differentiating cHL. Light chains could help, too.
torlakovic
2008-06-28 01:21
I would suggest to consider the difference in EBV latency status in this case. If LMP1+ and EBNA2 are positive, that would be latency type 3 and immunodeficiency-related, and if LMP1+ and EBNA2-, it would be latency type 2, which is compatible with cHL or some DLBCL. However, both PTLD and senile EBV-associated disease can also be type 2 in some cases. If EBNA2-, Oct2, BOB2, and PU.1 may help distinction between cHL and DLBCL. However, some cases remain classified as gray zone. In HIV+ patients, lymphocyte depleted cHL may be EBV+ and may have aggressive course. While the extent of B-cell markers and/or CD45 may be helpful, many variations have been described and I pay more attention to clinical data, EBV-status of the lesion, transcription factors' status, and morphology (as long as it is of B-cell lineage) to arrive to final diagnosis.
ugnius
2008-06-28 10:26
Thank you. BOB1 and Oct2 are unavailable at the moment. EBER under construction. The B clonality will be checked. Add IH in progress. Add photos will be appended.
ugnius
2008-07-15 20:16
The last IH: CD79a+; LCA+; CD43-(not included).
tzankov
2008-07-16 18:51
CD79a supports the diagnosis of EBV+ LPD over Hodgkin lymphoma
hurwitz
2008-07-20 17:43
Most of us agree that the final diagnosis in this case is:  
 
Age related EBV-associated LPD.  
 
Thanks to the submitter and the contributors to the discussion
ugnius
2008-07-31 16:03
Please find POLYCLONAL results of PCR attached.
ugnius
2008-07-31 16:04
After EBER introduction in September I will be back with EBV status.
ugnius
2008-07-31 16:09
Appologies: MONOCLONAL KAPPA with polyclonal background.
hurwitz
2008-08-01 17:23
Thanks Ugnius for the information on the clonality, it will be interesting to see the EBER results  
ugnius
2008-09-18 10:13
Please find a promised EBER (Hybridisation in situ, Ventana) positive result. It's the first EBER reaction in our centre.
hurwitz
2008-09-28 21:43
Congratulation to your first EBER1 ISH. My impression is that the staining is a bit too strong.
» pridėti komentarą (prisijungti)
Last modified: 2008-06-20 16:46:37